Lipella Pharmaceuticals Inc. (LIPO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jonathan Kaufman M.B.A., Ph.D. | Co-Founder, Chairman, CEO, President, Secretary & Treasurer | 233.3k | -- | 1967 |
| Dr. Michael B. Chancellor M.D. | Co-Founder, Chief Medical Officer & Director | 225k | -- | 1959 |
| Mr. Douglas Johnston CPA | Chief Financial Officer | 165k | -- | 1985 |
| Ms. Michele Gruber | Director of Operations | -- | -- | -- |
| Ms. Janet Okonski | Director of Clinical Operations | -- | -- | -- |
| Katie Johnston | Controller | -- | -- | -- |
Lipella Pharmaceuticals Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
April 1, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission